P63104 (1433Z_HUMAN) Homo sapiens (Human)
14-3-3 protein zeta/delta UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
68 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of the MST4 and 14-3-3 complex |
Heteromer Q9P289; | 100 | 1×GOL; 1×PE4; | |||
| 14-3-3 zeta complexed with S559 phosphorylated peptide derived from GPIb alpha cytoplasmic domain |
Heteromer P07359; | 100.0 | ||||
| 14-3-3 interaction with Rnd3 prenyl-phosphorylation motif |
Heteromer P61587; | 100.0 | 3×PE4; 2×FAR; | |||
| 14-3-3 in complex with SARS-COV2 N phospho-peptide |
Heteromer P0DTC9; | 100 | 2×ACT; 1×GOL; 1×BEZ; | |||
| 14-3-3 zeta in complex with the human Son of sevenless homolog 1 (SOS1) |
Heteromer Q07889; | 100.0 | 1×1PE; | |||
| Small-molecule stabilization of the 14-3-3/Gab2 PPI interface |
Heteromer Q9UQC2; | 100 | 2×5SO; 2×BEZ; 1×MG; | |||
| Binary complex of 14-3-3 zeta Glucocorticoid Receptor (GR) pT524 peptide stabilised by (R)-para chl… |
Heteromer P04150; | 100 | 2×BTB; 2×QJK; 1×MG; | |||
| Molecular basis for the recognition of phosphorylated and phosphoacetylated histone H3 by 14-3-3 |
Heteromer P68431; | 100.0 | ||||
| CRTC1 pSer151 peptide in complex with 14-3-3 zeta |
Heteromer Q6UUV9; | 100.0 | 1×GOL; | |||
| Binary complex of 14-3-3 zeta with Glucocorticoid Receptor (GR) pS617 peptide |
Heteromer P04150; | 100 | 1×SAL; 1×SO4; | |||
| Crystal structure of human 14-3-3 zeta in complex with PI4KIIIB peptide |
Heteromer Q9UBF8; | 100 | ||||
| Binary complex of 14-3-3 zeta with Glucocorticoid Receptor (GR) pT524 peptide |
Heteromer P04150; | 100 | ||||
| Crystal structure of human 14-3-3 zeta in complex with CFTR R-domain peptide pS753-pS768 |
Heteromer P13569; | 100.0 | 2×GLC; 4×CL; | |||
| 14-3-3 zeta complexed with S609 phosphorylated peptide derived from GPIb alpha cytoplasmic domain |
Heteromer P07359; | 100.0 | ||||
| Crystal structure of 14-3-3zeta in complex with a 8-carbon-linker cyclic peptide derived from ExoS |
Heteromer Q93SQ3; | 100 | ||||
| Human 14-3-3 isoform zeta in complex with a diphoyphorylated C-RAF peptide and Cotylenin A |
Heteromer P04049; | 100 | 2×K; 2×1F5; | |||
| CRTC1 pSer245 peptide in complex with 14-3-3 zeta |
Heteromer Q6UUV9; | 100 | 3×GOL; | |||
| Crystal structure of 14-3-3zeta in complex with a peptide derived from ExoS |
Heteromer Q93SQ3; | 100.0 | 10×P6G; | |||
| Small-molecule stabilization of the 14-3-3/Gab2 PPI interface |
Heteromer Q9UQC2; | 100 | 2×BEZ; | |||
| The molecular tweezer CLR01 stabilizes a disordered protein-protein interface |
Heteromer P30307; | 100 | 4×9SZ; 2×BEZ; | |||
| Structure of 14-3-3 zeta in complex with ASK1 14-3-3 binding motif |
Heteromer Q99683; | 100.0 | ||||
| Impaired binding of 14-3-3 to Raf1 is linked to Noonan and LEOPARD syndrome |
Heteromer P04049; | 100 | 1×PPI; | |||
| Impaired binding of 14-3-3 to Raf1 is linked to Noonan and LEOPARD syndrome |
Heteromer P04049; | 100 | 2×MG; 1×PPI; | |||
| Crystal structure of 14-3-3zeta in complex with an alkyne cross-linked cyclic peptide derived from … |
Heteromer Q93SQ3; | 100.0 | 1×BEZ; | |||
| Crystal Structure of 14-3-3 zeta with Chibby peptide |
Heteromer Q9Y3M2; | 100.0 | ||||
| CRTC1 pSer64 peptide in complex with 14-3-3 zeta |
Heteromer Q6UUV9; | 100 | ||||
| 14-3-3 with peptide |
Heteromer Q96RR4; | 100.0 | ||||
| 14-3-3 protein zeta in complex with Thr758 phosphorylated integrin beta2 peptide |
Heteromer P05107; P63103; | 100.0 | ||||
| Crystal structure of 14-3-3zeta in complex with a 12-carbon-linker cyclic peptide derived from ExoS |
Heteromer Q93SQ3; | 100 | ||||
| BRAF dimer bound to 14-3-3 |
Heteromer P15056; | 100 | 2×29L; | |||
| Structure of 14-3-3 zeta delta C with the bivalent tau-pS214-pS324 peptide |
Heteromer P10636; | 100.0 | ||||
| Molecular basis for the recognition of phosphorylated and phosphoacetylated histone H3 by 14-3-3 |
Heteromer P68431; | 100 | ||||
| Binary complex of 14-3-3 zeta with Glucocorticoid Receptor (GR) pT524 pS617 peptide |
Heteromer P04150; | 100.0 | ||||
| Structure of the LKB1 and 14-3-3 complex |
Heteromer Q15831; | 100 | ||||
| Apo BRAF dimer bound to 14-3-3 |
Heteromer P15056; | 100 | 1×EDO; | |||
| Dimeric (BRAF)2:(14-3-3)2 complex bound to SB590885 Inhibitor |
Heteromer P15056; | 100 | 2×215; | |||
| Binary complex of 14-3-3 zeta with ubiquitin specific protease 8 (USP8) pSer718 peptide |
Heteromer P40818; | 100.0 | ||||
| 14-3-3 isoform zeta in complex with a diphoyphorylated C-RAF peptide |
Heteromer P04049; | 100.0 | ||||
| Crystal Structure of 14-3-3 zeta in Complex with a Serine 124-phosphorylated TBC1D7 peptide |
Heteromer Q9P0N9; | 100.0 | 2×EDO; 8×UNX; | |||
| 14-3-3-zeta in complex with S1011 phosphorylated integrin alpha-4 peptide |
Heteromer P13612; | 100 | 2×GOL; | |||
| The molecular tweezer CLR01 stabilizes a disordered protein-protein interface |
Heteromer P30307; | 100.0 | 2×GOL; 2×BEZ; | |||
| The molecular tweezer CLR01 stabilizes a disordered protein-protein interface |
Heteromer P30307; | 100.0 | 4×9SZ; 2×BEZ; 3×GOL; | |||
| Structure of 14-3-3 zeta in complex with CaMKK2 14-3-3 binding motif |
Heteromer Q96RR4; | 100.0 | ||||
| Autoinhibited BRAF:(14-3-3)2:MEK complex with the BRAF RBD resolved |
Heteromer P15056; Q02750; | 100.0 | 2×ZN; 1×CHU; | |||
| Structure of a MAPK pathway complex |
Heteromer P15056; | 100 | ||||
| Autoinhibited BRAF:(14-3-3)2 complex with the BRAF RBD resolved |
Heteromer P15056; | 100.0 | 2×ZN; | |||
| Recognition of an intrachain tandem 14-3-3 binding site within protein kinase C epsilon |
Heteromer Q02156; | 100.0 | 1×PGE; | |||
| Crystal structure of human 14-3-3 zeta in complex with CFTR R-domain peptide pS753-pS768 and stabil… |
Heteromer P13569; | 100.0 | 1×FSC; | |||
| CRYSTAL STRUCTURE OF THE 14-3-3 ZETA:SEROTONIN N-ACETYLTRANSFERASE COMPLEX |
Heteromer Q29495; | 100 | 2×COT; | |||
| Crystal structure of 14-3-3[zeta]-LKB1 fusion protein | homo-2-mer | 100.0 | 3×GOL; 2×SO4; 6×TME; | |||
| 14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 1) | homo-2-mer | 100.0 | ||||
| Phosphorylation independent interactions between 14-3-3 and Exoenzyme S: from structure to pathogen… | homo-2-mer | 100.0 | 2×BEZ; | |||
| 14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 2) | homo-2-mer | 100.0 | ||||
| Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in p… | homo-2-mer | 100 | 2×DWE; 2×BEZ; 2×CA; 4×CL; 2×GOL; | |||
| Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in p… | homo-2-mer | 100.0 | 2×DWK; 2×BEZ; 2×GOL; 2×CA; 4×CL; | |||
| Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in p… | homo-2-mer | 100.0 | 2×DW8; 2×BEZ; 2×GOL; | |||
| Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in p… | homo-2-mer | 100.0 | 2×BEZ; 3×GOL; 2×CA; 4×CL; 2×DWQ; | |||
| X-ray induced covalent inhibition of 14-3-3 | homo-2-mer | 100 | 2×3RD; 2×NI; | |||
| 14-3-3 zeta chimera with 18E6 and fusicoccin | homo-2-mer | 96.94 | 1×GOL; 2×FSC; | |||
| 14-3-3 zeta bound to the phosphorylated 18E6 C-terminus | homo-2-mer | 96.94 | 4×GOL; | |||
| Crystal structure of the chimera of human 14-3-3 zeta and phosphorylated cytoplasmic loop fragment … | homo-2-mer | 98.61 | 4×EDO; 3×AZI; 1×BEZ; 1×PEG; | |||
| Crystal structure of 14-3-3zeta in complex with a cyclic peptide involving an adamantyl and a dicar… | homo-2-mer | 100.0 | 2×BEZ; | |||
| Crystal Structure of 14-3-3zeta in complex with a macrocyclic 8-mer peptide derived from ExoS | homo-2-mer | 100.0 | ||||
| Human 14-3-3 zeta fused to the BAD peptide including phosphoserine-74 | homo-2-mer | 98.25 | ||||
| 14-3-3 PROTEIN ZETA ISOFORM | homo-2-mer | 100.0 | ||||
| Crystal structure of human 14-3-3 zeta fused to the NPM1 peptide including phosphoserine-48 | homo-2-mer | 96.9 | ||||
| 14-3-3 PROTEIN ZETA BOUND TO R18 PEPTIDE | homo-2-mer | 100.0 | ||||
| 14-3-3 PROTEIN ZETA BOUND TO PS-RAF259 PEPTIDE | homo-2-mer | 100.0 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7q16.1.B | homo-2-mer | 0.82 | 93.36 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8ah2.1.A | monomer | 0.78 | 83.33 | |||